CRISPR and CRISPR-Associated (Cas) Genes Market Trends & Growth | 2027

 

Market Overview:

The CRISPR and CRISPR-associated (Cas) Genes Market was estimated to be USD 1,563.52 million in 2020, with a CAGR of 15.67% expected to reach USD 3,733.66 million by 2027.

The COVID-19 pandemic is expected to benefit the market by increasing demand for COVID-19 diagnostic tests. Sherlock Biosciences announced in May 2020 that it had received Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA) for its Sherlock CRISPR SARS-CoV-2 kit, which is used to detect the virus that causes COVID-19. The Sherlock CRISPR SARS-CoV-2 kit could provide results in about an hour, which was much faster than the other tests on the market at the time. Read More

Scope of the Report:

CRISPR-Cas9, an acronym for clustered regularly interspaced short palindromic repeats and CRISPR-associated protein 9, is a microbial adaptive immune system against viruses and plasmids that gives scientists the ability to change an organism’s DNA, according to the scope of the CRISPR and CRISPR-associated (Cas) Genes market (genome editing).

The market for CRISPR and CRISPR-associated (Cas) Genes is divided into three sections: product (Vector-based Cas and DNA-free Cas), application (Genome Engineering, Disease Models, Functional Genomics, and Others), and geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report provides the value (in USD million) for the aforementioned segments.

Read Full report


Comments

Popular Posts

Aviation Industry Set to Soar: Market to Hit USD 395.76 Billion by 2030 Amid Stable Growth

Recreational Boating Market Set to Reach USD 36.82 Billion by 2030: Key Growth Drivers and Trends

Kuwait Dairy Products Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Coffee Machine Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)